OncoTarget®500
Comprehensive Genomic Profiling Panel
OncoTarget® Myeloid68
An NGS-Based Test for Myeloid Leukemia

When cancer is diagnosed, finding treatment options is the top priority

OncoTarget® Series is our comprehensive genomic profiling solution to identify targeted immunotherapies
for advanced cancers – solid tumors or leukemias.
Available in 7-10 business days
FDA-Cleared (510k) test
Clear insights into therapy options
First FDA-Cleared IVD Comprehensive Genomic Profiling Panel
Sample reports
  • Sample Report of Breast Cancer
  • Sample Report of Colon Cancer
  • Sample Report of Lung Cancer
  • Sample Report of Prostate Cancer
Begin your journey. Our team is ready to get you started.